vs
Side-by-side financial comparison of Barnes & Noble Education, Inc. (BNED) and Insulet Corporation (PODD). Click either name above to swap in a different company.
Insulet Corporation is the larger business by last-quarter revenue ($761.7M vs $598.2M, roughly 1.3× Barnes & Noble Education, Inc.). Insulet Corporation runs the higher net margin — 12.0% vs 4.2%, a 7.8% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (33.9% vs 6.9%). Insulet Corporation produced more free cash flow last quarter ($89.5M vs $61.9M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (24.9% CAGR vs 20.0%).
Barnes & Noble Booksellers is an American bookseller with the largest number of retail outlets in the United States. The company operates approximately 700+ retail stores across the United States.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
BNED vs PODD — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $598.2M | $761.7M |
| Net Profit | $25.0M | $91.1M |
| Gross Margin | 21.7% | 69.5% |
| Operating Margin | 6.8% | 16.0% |
| Net Margin | 4.2% | 12.0% |
| Revenue YoY | 6.9% | 33.9% |
| Net Profit YoY | -49.7% | 157.3% |
| EPS (diluted) | $0.72 | $1.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $761.7M | ||
| Q4 25 | $598.2M | $783.7M | ||
| Q3 25 | $274.2M | $706.3M | ||
| Q2 25 | $233.0M | $649.1M | ||
| Q1 25 | $419.7M | $569.0M | ||
| Q4 24 | $559.7M | $597.5M | ||
| Q3 24 | $250.9M | $543.9M | ||
| Q2 24 | $192.7M | $488.5M |
| Q1 26 | — | $91.1M | ||
| Q4 25 | $25.0M | $101.6M | ||
| Q3 25 | $-18.3M | $87.6M | ||
| Q2 25 | $-23.0M | $22.5M | ||
| Q1 25 | $17.9M | $35.4M | ||
| Q4 24 | $43.2M | $100.7M | ||
| Q3 24 | $-103.9M | $77.5M | ||
| Q2 24 | $-41.9M | $188.6M |
| Q1 26 | — | 69.5% | ||
| Q4 25 | 21.7% | 72.6% | ||
| Q3 25 | 20.2% | 72.2% | ||
| Q2 25 | 30.3% | 69.7% | ||
| Q1 25 | 22.3% | 71.9% | ||
| Q4 24 | 23.0% | 72.1% | ||
| Q3 24 | 17.9% | 69.3% | ||
| Q2 24 | 28.7% | 67.7% |
| Q1 26 | — | 16.0% | ||
| Q4 25 | 6.8% | 18.7% | ||
| Q3 25 | -8.4% | 16.7% | ||
| Q2 25 | -4.9% | 18.7% | ||
| Q1 25 | 4.5% | 15.6% | ||
| Q4 24 | 8.4% | 18.3% | ||
| Q3 24 | -15.4% | 16.2% | ||
| Q2 24 | -16.3% | 11.2% |
| Q1 26 | — | 12.0% | ||
| Q4 25 | 4.2% | 13.0% | ||
| Q3 25 | -6.7% | 12.4% | ||
| Q2 25 | -9.9% | 3.5% | ||
| Q1 25 | 4.3% | 6.2% | ||
| Q4 24 | 7.7% | 16.9% | ||
| Q3 24 | -41.4% | 14.2% | ||
| Q2 24 | -21.7% | 38.6% |
| Q1 26 | — | $1.30 | ||
| Q4 25 | $0.72 | $1.42 | ||
| Q3 25 | $-0.54 | $1.24 | ||
| Q2 25 | $2.97 | $0.32 | ||
| Q1 25 | $0.59 | $0.50 | ||
| Q4 24 | $1.63 | $1.38 | ||
| Q3 24 | $-7.69 | $1.08 | ||
| Q2 24 | $-15.68 | $2.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.7M | $480.4M |
| Total DebtLower is stronger | $122.5M | $18.6M |
| Stockholders' EquityBook value | $283.2M | $1.3B |
| Total Assets | $1.1B | $3.0B |
| Debt / EquityLower = less leverage | 0.43× | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $480.4M | ||
| Q4 25 | $11.7M | — | ||
| Q3 25 | $7.3M | — | ||
| Q2 25 | $9.1M | — | ||
| Q1 25 | $9.2M | — | ||
| Q4 24 | $11.6M | — | ||
| Q3 24 | $8.2M | — | ||
| Q2 24 | $10.5M | — |
| Q1 26 | — | $18.6M | ||
| Q4 25 | $122.5M | $930.8M | ||
| Q3 25 | $170.0M | $934.9M | ||
| Q2 25 | $103.1M | $939.0M | ||
| Q1 25 | $141.2M | $1.6B | ||
| Q4 24 | $177.6M | $1.3B | ||
| Q3 24 | $221.9M | $1.4B | ||
| Q2 24 | $196.3M | $1.4B |
| Q1 26 | — | $1.3B | ||
| Q4 25 | $283.2M | $1.5B | ||
| Q3 25 | $256.5M | $1.4B | ||
| Q2 25 | $272.2M | $1.5B | ||
| Q1 25 | $292.9M | $1.3B | ||
| Q4 24 | $211.4M | $1.2B | ||
| Q3 24 | $149.8M | $1.1B | ||
| Q2 24 | $80.4M | $998.4M |
| Q1 26 | — | $3.0B | ||
| Q4 25 | $1.1B | $3.2B | ||
| Q3 25 | $950.8M | $3.0B | ||
| Q2 25 | $790.3M | $3.5B | ||
| Q1 25 | $1.1B | $3.5B | ||
| Q4 24 | $1.0B | $3.1B | ||
| Q3 24 | $973.2M | $3.0B | ||
| Q2 24 | $909.9M | $2.9B |
| Q1 26 | — | 0.01× | ||
| Q4 25 | 0.43× | 0.61× | ||
| Q3 25 | 0.66× | 0.68× | ||
| Q2 25 | 0.38× | 0.64× | ||
| Q1 25 | 0.48× | 1.21× | ||
| Q4 24 | 0.84× | 1.07× | ||
| Q3 24 | 1.48× | 1.21× | ||
| Q2 24 | 2.44× | 1.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $66.2M | $113.8M |
| Free Cash FlowOCF − Capex | $61.9M | $89.5M |
| FCF MarginFCF / Revenue | 10.4% | 11.8% |
| Capex IntensityCapex / Revenue | 0.7% | 3.2% |
| Cash ConversionOCF / Net Profit | 2.65× | 1.25× |
| TTM Free Cash FlowTrailing 4 quarters | $-4.6M | $415.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $113.8M | ||
| Q4 25 | $66.2M | $183.3M | ||
| Q3 25 | $-67.6M | $125.7M | ||
| Q2 25 | $52.6M | $196.5M | ||
| Q1 25 | $-41.9M | $63.8M | ||
| Q4 24 | $47.4M | $147.7M | ||
| Q3 24 | $-143.5M | $98.5M | ||
| Q2 24 | $81.7M | $96.5M |
| Q1 26 | — | $89.5M | ||
| Q4 25 | $61.9M | $48.2M | ||
| Q3 25 | $-71.3M | $100.1M | ||
| Q2 25 | $49.5M | $177.9M | ||
| Q1 25 | $-44.7M | $51.5M | ||
| Q4 24 | $44.4M | $94.1M | ||
| Q3 24 | $-147.5M | $71.8M | ||
| Q2 24 | $79.1M | $74.0M |
| Q1 26 | — | 11.8% | ||
| Q4 25 | 10.4% | 6.2% | ||
| Q3 25 | -26.0% | 14.2% | ||
| Q2 25 | 21.3% | 27.4% | ||
| Q1 25 | -10.7% | 9.1% | ||
| Q4 24 | 7.9% | 15.7% | ||
| Q3 24 | -58.8% | 13.2% | ||
| Q2 24 | 41.1% | 15.1% |
| Q1 26 | — | 3.2% | ||
| Q4 25 | 0.7% | 17.2% | ||
| Q3 25 | 1.4% | 3.6% | ||
| Q2 25 | 1.3% | 2.9% | ||
| Q1 25 | 0.7% | 2.2% | ||
| Q4 24 | 0.5% | 9.0% | ||
| Q3 24 | 1.6% | 4.9% | ||
| Q2 24 | 1.4% | 4.6% |
| Q1 26 | — | 1.25× | ||
| Q4 25 | 2.65× | 1.80× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | — | 8.73× | ||
| Q1 25 | -2.34× | 1.80× | ||
| Q4 24 | 1.10× | 1.47× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | 0.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BNED
| Course Materials Product | $459.3M | 77% |
| General Merchandise Product | $112.9M | 19% |
| Serviceand Other | $26.1M | 4% |
PODD
| Omnipod | $515.6M | 68% |
| International Omnipod | $242.9M | 32% |
| Drug Delivery | $3.3M | 0% |
